COMMUNIQUÉS West-GlobeNewswire

Dr. Anosh Ahmed’s Philanthropic Vision: Empowering Underserved Chicago Communities
20/06/2025
Chicago physician and entrepreneur Dr. Anosh Ahmed expands long-term community initiatives focused on healthcare, education, and economic relief through the Anosh Ahmed Foundation. Dr. Anosh Ahmed Image CHICAGO, June 20 [...]
Ipsen reçoit un avis positif du CHMP pour Cabometyx® dans les tumeurs neuroendocrines avancées précédemment traitées
20/06/2025
S’il est approuvé, Cabometyx® sera le premier et unique traitement systémique autorisé dans l’Union européenne pour les tumeurs neuroendocrines précédemment traitées, indépendamment de la localisation de la tumeur, de [...]
Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors
20/06/2025
If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue- [...]
CHMP recommends third indication for darolutamide for patients with advanced prostate cancer
20/06/2025
ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST CHMP recommends third indication for darolutamide for patients with advanced prostate cancer CHMP adopts positive opinion for the marketing authorisation of [...]
Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
20/06/2025
Positive recommendation based on resmetirom’s favorable profile including positive results from the pivotal Phase 3 MAESTRO-NASH trial European Commission decision expected in August 2025 ; if approved, resmetirom will [...]
DARZALEX® (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple myeloma
20/06/2025
If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease interception 1 [...]
IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant
20/06/2025
Pending the European Commission final decision, regimen offers a new standard of care for eligible MCL patients 1 , 2 Positive opinion reinforces Phase 3 TRIANGLE study results by the European MCL Network, showing [...]
Communiqué de presse : Dupixent est approuvé aux États-Unis comme le seul médicament ciblé pour traiter les patients atteints de pemphigoïde bulleuse
20/06/2025
Dupixent est approuvé aux États-Unis comme le seul médicament ciblé pour traiter les patients atteints de pemphigoïde bulleuse L’approbation est basée sur des résultats pivots montrant des améliorations de la rémission [...]
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
20/06/2025
Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral [...]
Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)
20/06/2025
Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP BP is a chronic, debilitating and relapsing [...]
NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update
20/06/2025
TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotech company developing exosome-based therapies for [...]
CARBIOS présente les résultats de son Assemblée Générale du 19 juin 2025 et la composition de son Conseil d’administration
20/06/2025
Clermont-Ferrand (France), le 20 juin 2025 (06h45 CEST). CARBIOS, (Euronext Growth Paris : ALCRB), pionnière dans le développement et l'industrialisation de technologies biologiques pour réinventer le cycle de vie des [...]
Carbios presents the results of its Annual General Meeting of 19 June 2025 and the composition of its Board of Directors
20/06/2025
Clermont-Ferrand (France), June 20, 2025 (6:45 am CEST). CARBIOS , (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20/06/2025
MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
20/06/2025
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite [...]
HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support
20/06/2025
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care BROOKLYN, June 19 [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share
19/06/2025
SAN JUAN CAPISTRANO, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plans
19/06/2025
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is excited to announce [...]
Premier Health Announces a Strategic Review Process to Enhance Shareholder Value
19/06/2025
MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “ Company ” or “ Premier Health ”), a leading Canadian health tech company, today announced that its Board of Directors (the “ [...]

Pages